Millions of diabetic patients are waiting for better treatment options, ideally by replenishing the lost or dysfunctional insulin-producing β cell mass. Yi et al. (2013) now identify Betatrophin, a hormone that specifically increases β cell proliferation with promising therapeutic potential.